ABBV stock news
This page provides real-time market news, earnings updates, and company announcements related to AbbVie Inc. (ABBV).
All content is aggregated from trusted financial media and market data sources to help investors stay informed about key market movements and corporate developments.
Last updated as of 2026-04-12 23:31 EST
AbbVie (ABBV) Shares Decline Even as Market Rises: Key Points to Consider
101 finance2026-04-06 22:49:02
Terns investors believe Merck’s $53 acquisition offer undervalues the company—arbitrage involves the possibility of competing bids or the deal falling through
101 finance2026-04-07 13:28:02
AbbVie’s Reduced Earnings Outlook Overshadowed by Over $30 Billion Growth Engine in Immunology
101 finance2026-04-08 04:06:45
AtaiBeckley's BPL-003 May Lay the Foundation for a Scalable Mental Health System—The Outcome of 2026 Phase 3 Studies Will Determine Its Future
101 finance2026-04-08 10:24:56
AbbVie's Skyrizi and Rinvoq Surge: Market Underestimates 2026 Growth Catalyst
101 finance2026-04-08 15:00:48
3 Absurdly Cheap Dividend Stocks to Buy in April 2026
101 finance2026-04-08 19:21:43
PhRMA's Leadership Changes as Industry Divisions Widen and Price Disputes Intensify
101 finance2026-04-08 19:42:41
Nxera Pharma’s $1.2B Milestone Deal with AbbVie Depends on Upcoming Performance
101 finance2026-04-09 00:00:55
Amneal Launches Bimatoprost Ophthalmic Solution, 0.01%
Finviz2026-04-09 12:03:53
ABBV: Call Open Interest Soars at $230 as Legal and Earnings Moves Shape the Path Forward
101 finance2026-04-09 18:34:15
Battle of Big Pharma: Is AbbVie Outperforming Pfizer in the Stock Market?
101 finance2026-04-10 14:39:35
Analysts Love JBVIO, but Cash Flows Tell a Cautious Story
101 finance2026-04-11 00:21:51
Ocular Rallies 15% as Big Money Sells Out
101 finance2026-04-11 01:09:44
AbbVie's Decline: Is This a Bargain or a Pitfall? Examining the Scenario After the Guidance Reduction
101 finance2026-04-11 05:51:41
AbbVie's 340B Lawsuit: A Margin Catalyst Or Regulatory Noise?
101 finance2026-04-11 06:57:49
AbbVie Showcases Late-Breaking Phase 2 Data for Mirvetuximab Soravtansine-gynx (ELAHERE) in Platinum-Sensitive Ovarian Cancer (PSOC) at SGO 2026
Finviz2026-04-12 11:18:39
AbbVie's ELAHERE Demonstrates Unexpected PSOC Effectiveness, Boosting Anticipated Expansion
101 finance2026-04-12 11:51:56
MoonLake Rises on Retail Buzz, But Big Money Stays on the Sidelines
101 finance2026-04-12 23:39:48
MapLight's 44% Rally Meets Bearish Tech Signals
101 finance2026-04-13 00:09:55
IOVA Rises on Strong Buy — But Charts Signal Trouble
101 finance2026-04-13 00:45:47
Institutional Money Floods Organon as Analysts Warn and Charts Conflicted
101 finance2026-04-13 01:06:43
Travere Climbs 6.28% as Biotech Sector Changes and Analysts Express Optimism
101 finance2026-04-13 01:57:46
KYTX Climbs Amid Optimistic Outlook, Yet Major Investors Are Pulling Out
101 finance2026-04-13 03:00:41
Guardant drops 7.1% as major investors take advantage of the decline
101 finance2026-04-13 03:10:11
AbbVie's Skyrizi and Rinvoq Surge: Market Underestimates 2026 Growth Catalyst
101 finance2026-04-08 15:00:48
3 Absurdly Cheap Dividend Stocks to Buy in April 2026
101 finance2026-04-08 19:21:43
PhRMA's Leadership Changes as Industry Divisions Widen and Price Disputes Intensify
101 finance2026-04-08 19:42:41
Nxera Pharma’s $1.2B Milestone Deal with AbbVie Depends on Upcoming Performance
101 finance2026-04-09 00:00:55
Amneal Launches Bimatoprost Ophthalmic Solution, 0.01%
Finviz2026-04-09 12:03:53
ABBV: Call Open Interest Soars at $230 as Legal and Earnings Moves Shape the Path Forward
101 finance2026-04-09 18:34:15
Battle of Big Pharma: Is AbbVie Outperforming Pfizer in the Stock Market?
101 finance2026-04-10 14:39:35
Analysts Love JBVIO, but Cash Flows Tell a Cautious Story
101 finance2026-04-11 00:21:51
Ocular Rallies 15% as Big Money Sells Out
101 finance2026-04-11 01:09:44
AbbVie's Decline: Is This a Bargain or a Pitfall? Examining the Scenario After the Guidance Reduction
101 finance2026-04-11 05:51:41
AbbVie's 340B Lawsuit: A Margin Catalyst Or Regulatory Noise?
101 finance2026-04-11 06:57:49
AbbVie Showcases Late-Breaking Phase 2 Data for Mirvetuximab Soravtansine-gynx (ELAHERE) in Platinum-Sensitive Ovarian Cancer (PSOC) at SGO 2026
Finviz2026-04-12 11:18:39
AbbVie's ELAHERE Demonstrates Unexpected PSOC Effectiveness, Boosting Anticipated Expansion
101 finance2026-04-12 11:51:56
MoonLake Rises on Retail Buzz, But Big Money Stays on the Sidelines
101 finance2026-04-12 23:39:48
MapLight's 44% Rally Meets Bearish Tech Signals
101 finance2026-04-13 00:09:55
IOVA Rises on Strong Buy — But Charts Signal Trouble
101 finance2026-04-13 00:45:47
Institutional Money Floods Organon as Analysts Warn and Charts Conflicted
101 finance2026-04-13 01:06:43
Travere Climbs 6.28% as Biotech Sector Changes and Analysts Express Optimism
101 finance2026-04-13 01:57:46
KYTX Climbs Amid Optimistic Outlook, Yet Major Investors Are Pulling Out
101 finance2026-04-13 03:00:41
Guardant drops 7.1% as major investors take advantage of the decline
101 finance2026-04-13 03:10:11
ABBV stock chart
ABBV stock detailsABBV stock price change
On the last trading day, ABBV stock closed at 207.94 USD, with a price change of -2.10% for the day.
Trade stock perpsAbout Bitget
The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).
Learn more